tiprankstipranks
Trending News
More News >
Metlife (GB:0K0X)
LSE:0K0X
UK Market
Advertisement

Metlife (0K0X) Earnings Dates, Call Summary & Reports

Compare
0 Followers

Earnings Data

Report Date
Feb 04, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
2.39
Last Year’s EPS
2.09
Same Quarter Last Year
Based on 14 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 05, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call highlighted significant growth in earnings, strong performance in the PRT and Asia segments, and efficient expense management. However, there were notable challenges, including the impact of the Mexican tax law change and reduced earnings from reinsurance transactions. Overall, the positive aspects of the results outweigh the negative ones.
Company Guidance
During the MetLife Third Quarter 2025 Earnings Conference Call, the company provided several metrics and insights regarding its performance and strategic initiatives. MetLife reported strong third quarter results with adjusted earnings of $1.6 billion or $2.37 per share, marking a 22% per share increase from the prior year period. Excluding notable items, adjusted earnings were $1.6 billion or $2.34 per share, up 21% from a year ago. Variable investment income was a significant contributor, posting $483 million, above the implied quarterly outlook of $425 million, driven by higher private equity returns. The company's global retirement liability origination platform is experiencing growth, particularly in the U.S., U.K., and Japan. The Group Benefits segment posted adjusted earnings of $457 million, up 6% year-over-year, while the Retirement and Income Solutions segment saw adjusted earnings rise 15% to $423 million. MetLife's direct expense ratio improved to 11.6% for the quarter. In Asia, adjusted earnings surged 36% to $473 million, with sales increasing 34% on a constant currency basis. The company also highlighted its strategic capital deployment, with $875 million returned to shareholders through dividends and share repurchases during the quarter. MetLife's economic solvency ratio in Japan is expected to range between 170% to 190% by March 2026.
Strong Earnings Growth
MetLife reported adjusted earnings of $1.6 billion or $2.37 per share, a 22% increase per share from the prior year period. Excluding notable items, adjusted earnings were $1.6 billion or $2.34 per share, a 21% increase from a year ago.
Record PRT Transactions
MetLife secured $12 billion of Pension Risk Transfer (PRT) transactions in the fourth quarter, making it a record quarter for the company.
Asia Sales Surge
Adjusted earnings in Asia were $473 million, a 36% increase from the prior year quarter. Sales surged 34% on a constant currency basis, driven by a 31% increase in Japan.
Strong Group Benefits Performance
Group Benefits adjusted earnings, excluding notable items, totaled $457 million, up 6% from a year ago, reflecting solid underwriting results.
High Return on Equity
MetLife generated an adjusted return on equity, excluding notables, of 16.7%, near the top of its target range of 15% to 17%.
Efficient Expense Management
The direct expense ratio was 11.6% in the third quarter, below the full-year target of 12.1%, due to productivity and efficiency gains.
Increased Value of New Business
In 2024, MetLife deployed $3.4 billion of capital to support new business origination with an average internal rate of return of 19% and a payback period of 5 years.

Metlife (GB:0K0X) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

GB:0K0X Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 04, 2026
2025 (Q4)
2.39 / -
2.09
Nov 05, 2025
2025 (Q3)
2.32 / 2.34
1.9520.00% (+0.39)
Aug 06, 2025
2025 (Q2)
2.15 / 2.02
2.28-11.40% (-0.26)
Apr 30, 2025
2025 (Q1)
2.00 / 1.96
1.837.10% (+0.13)
Feb 05, 2025
2024 (Q4)
2.11 / 2.09
1.8314.21% (+0.26)
Oct 30, 2024
2024 (Q3)
2.17 / 1.95
1.97-1.02% (-0.02)
Jul 31, 2024
2024 (Q2)
2.10 / 2.28
1.9417.53% (+0.34)
May 01, 2024
2024 (Q1)
1.84 / 1.83
1.5220.39% (+0.31)
Jan 31, 2024
2023 (Q4)
1.88 / 1.83
1.5518.06% (+0.28)
Nov 01, 2023
2023 (Q3)
1.94 / 1.97
1.2162.81% (+0.76)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

GB:0K0X Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 05, 2025
$79.58$76.38-4.02%
Aug 06, 2025
$75.53$72.77-3.66%
Apr 30, 2025
$72.80$74.37+2.15%
Feb 05, 2025
$82.94$80.87-2.50%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Metlife (GB:0K0X) report earnings?
Metlife (GB:0K0X) is schdueled to report earning on Feb 04, 2026, After Close (Confirmed).
    What is Metlife (GB:0K0X) earnings time?
    Metlife (GB:0K0X) earnings time is at Feb 04, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Metlife stock?
          The P/E ratio of Metlife is N/A.
            What is GB:0K0X EPS forecast?
            GB:0K0X EPS forecast for the fiscal quarter 2025 (Q4) is 2.39.

              Metlife (GB:0K0X) Earnings News

              MetLife (NYSE:MET) Posts Gloomy Q4 Results
              Premium
              Market News
              MetLife (NYSE:MET) Posts Gloomy Q4 Results
              3y ago
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis